John Matsoukas

Title: Innovations by Inventor John Matsoukas

Introduction

John Matsoukas, based in Patras, Greece, is a notable inventor with an impressive portfolio comprising two patents. His innovations in the field of pharmaceuticals focus on the development of conjugates and imidazole compounds that have significant implications for treating immune disorders and hypertension.

Latest Patents

Matsoukas's latest patents include:

1. **Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)** - This invention involves a conjugate that includes mannan and an epitope comprising a peptide fragment of proteins such as myelin basic protein (MBP), myelin oligodentrocyte glycoprotein (MOG), or proteolipid protein (PLP). The peptide fragment can exist in linear or cyclic forms, linked to mannan through a [(Lys-Gly)] bridge. This invention extends to pharmaceutical compositions utilizing these conjugates for the preparation of medicaments aimed at treating immune disorders.

2. **1,3,5-substituted imidazoles and their use in the treatment of hypertension** - This invention encapsulates novel 1,5 and 1,3,5-substituted imidazole compounds, available in both hydrophilic and lipophilic forms. These compounds function as angiotensin II ATI receptor antagonists and are suitable for transdermal delivery. The patent further outlines pharmaceutical compositions containing these compounds, as well as methods for their preparation and application in treating hypertension and cardiovascular diseases.

Career Highlights

Throughout his career, John Matsoukas has contributed significantly to the pharmaceutical industry by working with several prominent companies, including Vianex S.A. and Eldrug S.A. His expertise in the development of innovative medicinal compounds has positioned him as a valuable figure in medical research and development.

Collaborations

Matsoukas has collaborated with esteemed professionals in his field, including Theodoros Tselios and Vasso Apostolopoulos. These partnerships have further enriched his work, fostering advancements in pharmaceutical sciences and the development of new therapeutic strategies.

Conclusion

John Matsoukas continues to push the boundaries of innovation in the pharmaceutical sector. His inventions not only demonstrate his commitment to improving health outcomes but also highlight the potential for novel therapeutic interventions in the treatment of complex medical conditions. With a strong foundation of collaboration and expertise, Matsoukas stands as an inspiring figure in the landscape of modern invention.